Skip to content
Recall Observatory FDA recall evidence

Drug product

Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58

D-1436-2014

June 17, 2014

Class III

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 68610
Status
Terminated
Classification
Class III
Quantity
1104 blister packs
Official record key
drug-enforcement:D-1436-2014

Official wording

Reason: Failed Impurities/Degradation Specifications: out of specification impurity test results.

Code information: Lot 3805324A Exp. 11/14

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification